These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
    Author: Magdzik W.
    Journal: Przegl Epidemiol; 2004; 58(2):241-51. PubMed ID: 15521103.
    Abstract:
    Meningitis caused by Neisseria meningitidis is one of the most frequent and most serious, with fatal rate between few up to 20%. Majority of cases are caused by Neisseria meningitidis of serological groups A, B, C, as well as Y and W 135. Vaccination is the most effective prophylactic measure against meningococcal meningitidis. Polysaccharide, not conjugated vaccines against Neisseria meningitidis serological groups A, C, W 135, Y effective for children over 2 years old, adolescents and adults as well as vaccine against serogroup C conjugated with protein carrier, effective for children over 2 months of life, adolescents and adults are used. Conjugated vaccine against serological group C was used in 1998/1999 in Great Britain in the mass vaccination of infants in 2, 3, 4 months of life, children and adolescents up to 17. In Poland as well as in other European countries serological group B is an etiological factor of majority of cases caused by Neisseria meningitidis. Intensive studies are performed in the field on effective, safety, cheap vaccine against all serological groups of Neisseria meningitidis.
    [Abstract] [Full Text] [Related] [New Search]